AMALY — SHARIAH COMPLIANCE REPORT
==================================
Symbol: CURX
Report Date: 2026-04-07
Full Report: https://amaly.io/stock/CURX

EXECUTIVE SUMMARY
------------------
Compliance Status: COMPLIANT
Quality Rating: AAA
Description: CureVac N.V. (CURX), a biotechnology company focused on mRNA-based therapeutics and vaccines, exhibits robust Shariah compliance. Financial ratios are exceptionally low and meet all major screening standards, with no non-compliant business activities identified. The company is included in all major Shariah indices, affirming its eligibility for Islamic investment portfolios. ESG factors align well with Islamic principles, showing low risk and positive societal impact through healthcare innovation. Overall, CURX presents a high-quality compliant investment opportunity.

Purification Requirement: 0.00%
Index Inclusion: Included in S&P Dow Jones Shariah Indices, MSCI Islamic Indices, FTSE Shariah Indices, and Dow Jones Islamic Market (DJIM)

KEY FINANCIAL METRICS
----------------------
Debt Ratio: 0.0%
Liquidity Ratio: 0.0%
Interest Income Ratio: 0.0%
Purification Required: 0.00%

INDEX INCLUSION STATUS
-----------------------
S&P Shariah: INCLUDED
MSCI Islamic: INCLUDED
DJIM: INCLUDED
FTSE Shariah: INCLUDED
Total: 4 of 4
Last Verified: 2025-12-31

REPORTING PERIOD
-----------------
Latest Annual Report: FY 2024
Latest Quarterly Data: Q3 2025
Trend Period: FY 2020 to FY 2025
Data Retrieved: 2026-02-26T12:00:00Z

---
Full interactive report: https://amaly.io/stock/CURX
Provided by Amaly (https://amaly.io) — Shariah Compliant Stock Screener
Disclaimer: This data is for informational purposes only and does not constitute financial or religious advice.